GOVX
NASD GeoVax Labs, Inc.$0.2810 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2810, $0.0189 below the day’s high of $0.2999
- YTD change
- -93.43%
- vs 20-day SMA
- -21.14%
- vs 200-day SMA
- -82.33%
Price ranges
Price & Performance
-0.95 (-77.15%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $13,125.0000
- GOVX is down 93% since the beginning of the year
- GOVX is down 98% over the past 12 months
- GOVX is down 40% over the past 1 month
- 4% of all GOVX investors are betting against GOVX
GOVX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -49.4%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- -12.79%
- vs 8-day SMA
- -10.54%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola-Zaire, Ebola-Sudan, Lassa, Marburg, Zika virus and malaria. The company was founded in June 1988 and is headquartered in Smyrna, GA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
